PositiveID - PSID Competitors

Arrayit (OTCMKTS:ARYC) and PositiveID (OTCMKTS:PSID) are both medical companies, but which is the better business? We will contrast the two companies based on the strength of their dividends, valuation, analyst recommendations, media sentiment, institutional ownership, risk, profitability, community ranking and earnings.

Do analysts prefer ARYC or PSID?

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Arrayit	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	N/A
PositiveID	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	N/A

Does the media refer more to ARYC or PSID?

In the previous week, PositiveID had 1 more articles in the media than Arrayit. MarketBeat recorded 1 mentions for PositiveID and 0 mentions for Arrayit. Arrayit's average media sentiment score of 0.00 beat PositiveID's score of -0.41 indicating that Arrayit is being referred to more favorably in the media.

Company	Overall Sentiment
Arrayit	Neutral
PositiveID	Neutral

Is ARYC or PSID more profitable?

Company	Net Margins	Return on Equity	Return on Assets
Arrayit	N/A	N/A	N/A
PositiveID	N/A	N/A	N/A

Does the MarketBeat Community favor ARYC or PSID?

PositiveID received 25 more outperform votes than Arrayit when rated by MarketBeat users. Likewise, 68.00% of users gave PositiveID an outperform vote while only 65.81% of users gave Arrayit an outperform vote.

Company	Underperform	Outperform
Arrayit	Outperform Votes 77 65.81%	Underperform Votes 40 34.19%
PositiveID	Outperform Votes 102 68.00%	Underperform Votes 48 32.00%

Which has stronger earnings and valuation, ARYC or PSID?

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Arrayit	N/A	N/A	N/A	N/A	N/A
PositiveID	N/A	N/A	N/A	N/A	N/A

Summary

PositiveID beats Arrayit on 3 of the 4 factors compared between the two stocks.